REN and primary aldosteronism: In daily clinical practice, the renin-to-aldosterone-ratio (RAR), which is the reciprocal of the ratio that is commonly used to screen for primary aldosteronism (aldosterone-to-renin-ratio, ARR), has been proposed to assess the efficacy of RAAS antagonism, showing the real-life effectiveness of ACE-I or ARBs therapy.